Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-19

Clinical Trial Update: Effective Dose of Remimazolam for Sedation in Patients Undergoing Lower Extremity Surgery Under Spinal Anesthesia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial reports on the effective dose of remimazolam for sedation in patients undergoing lower extremity surgery under spinal anesthesia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remimazolam (remimazolam)

Snippet

Sponsor: Asan Medical Center | Conditions: Remimazolam, Orthopedic Procedures | Phase 4 | Status: COMPLETED